Millennium Management
CHRS icon

Millennium Management’s Coherus Oncology CHRS Stock Holding History

Millennium Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-36,000
Closed -$481K – 3816
2017
Q3 		$481K Hold
36,000
– – ﹤0.01% 2856
2017
Q2 		$517K Buy
+36,000
New +$692K ﹤0.01% 2784
2016
Q4 		– Sell
-10,000
Closed -$268K – 3366
2016
Q3 		$268K Buy
+10,000
New +$273K ﹤0.01% 2864

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Millennium Management's CHRS Position: Q1 2026 in Review

Millennium Management reduced its Coherus Oncology (CHRS) stake by 53% in Q1 2026, selling an estimated $619K and leaving 311,986 shares worth $527K. The position accounts for ﹤0.01% of the portfolio, ranked #4742.

Millennium Management first reported a position in CHRS in Q1 2015 and has held it in 38 quarters since. The position peaked at $27M in Q3 2016. 157 funds tracked by Wall St. Rank hold CHRS as of Q1 2026.

  • Millennium Management held 311,986 shares of Coherus Oncology worth $527K as of Q1 2026.
  • Millennium Management sold 348,465 Coherus Oncology shares in Q1 2026, an estimated $619K.
  • Coherus Oncology made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4742 holding.
  • Millennium Management first reported a position in Coherus Oncology in Q1 2015 and has held it in 38 quarters since.
  • Millennium Management's Coherus Oncology position peaked at $27M in Q3 2016.
  • 157 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.